You are adding an alert for:
The response to ranibizumab therapy after three injections predicts 12-month outcomes in DME in the absence of rescue laser therapy.
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: